Haem III (HL; NHL) Flashcards
(72 cards)
Describe what is meant by Hodgkin’s lymphoma
Uncontrolled proliferation of B-lymphocytes, causing lymphadenopathy
The infection of which pathogen is linked to / often precedes HL? [1]
Epstein-Barr Virus
State 4 risk factors for HL [4]
EBV
Immunosuppression:
* Organ transplantation
* Immunosuppressant therapies
* Patients with HIV
Autoimmune conditions
* rheumatoid arthritis
* systemic lupus erythematosus
* sarcoidosis
Familial
Which autoimmune conditions increase the liklihood of HL? [3]
- rheumatoid arthritis
- systemic lupus erythematosus
- sarcoidosis
What are the two types of HL? [2]
Classical Hodgkin’s lymphoma (95%)
Nodular lymphocyte-predominant Hodgkin’s lymphoma (5%)
Describe the features of nodular lymphocyte-predominant Hodgkin’s lymphoma (5%) [4]
- More commonly affects males (75%)
- Not associated with EBV
- Absence of Reed-Sternberg (RS) cells, and is characterised by LP (“popcorn”) cells
- Presents with peripheral adenopathy, and is the only type of Hodgkin’s lymphoma that affects the mesenteric lymph nodes
Which of the following types of classical HL is the most common?
Lymphocyte-depleted
Nodular sclerosis
Lymphocyte-rich
Mixed cellularity
Nodular sclerosis
What are the 4 subtypes of classical Hodgkins Lymphoma? [4]
Nodular sclerosis:
- Most common subtype, accounts for around 70% of cHL.
Mixed cellularity:
- Accounts for around 20% of cHL.
Lymphocyte-rich:
- Accounts for around 5% of cHL. Has the best prognosis.
Lymphocyte-depleted:
- Rare, accounting for < 1% of cHL. Has the the worst prognosis.
Which of the following types of classical HL has the worst prognosis?
Lymphocyte-depleted
Nodular sclerosis
Lymphocyte-rich
Mixed cellularity
Which of the following types of classical HL has the worst prognosis?
Lymphocyte-depleted
Which of the following types of classical HL has the best prognosis?
Lymphocyte-depleted
Nodular sclerosis
Lymphocyte-rich
Mixed cellularity
Which of the following types of classical HL has the best prognosis?
Lymphocyte-rich
Which of the following types of classical HL is most associated with HIV patients?
Lymphocyte-depleted
Nodular sclerosis
Lymphocyte-rich
Mixed cellularity
Lymphocyte-depleted
Which of the following types of classical HL is most associated with older patients
Lymphocyte-depleted
Nodular sclerosis
Lymphocyte-rich
Mixed cellularity
Which of the following types of classical HL is most associated with older patients
Lymphocyte-rich
Which of the following types of classical HL is most associated with mediastinal lymphadenopathy and bulk nodes?
Lymphocyte-depleted
Nodular sclerosis
Lymphocyte-rich
Mixed cellularity
Nodular sclerosis
Which of the following types of classical HL is most associated with peripheral adenopathy and spleen involvement?
Lymphocyte-depleted
Nodular sclerosis
Lymphocyte-rich
Mixed cellularity
Mixed cellularity
Which of the following types of classical HL is most associated with retroperitoneal adenopathy and abdominal lymphadenopathy?
Lymphocyte-depleted
Nodular sclerosis
Lymphocyte-rich
Mixed cellularity
Which of the following types of classical HL is most associated with retroperitoneal adenopathy and abdominal lymphadenopathy?
Lymphocyte-depleted
Which of the following types of classical HL are most asscoiated with EBV? [2]
Lymphocyte-depleted
Nodular sclerosis
Lymphocyte-rich
Mixed cellularity
Mixed cellularity
Lymphocyte-depleted
How do you stage lymphomas? [1]
Lecture content
PET scans
Describe the classical clinical features of HL [5]
Lymphadenopathy:
- Painless
- Non-tender and firm / rubbery
- Asymmetrical
- Cervical or mediastinal involvement
- Pain in lymph nodes after drinking alcohol
Describe the additional clinical features of HL than lymphadenopathy [5]
Pel-Ebstein fever
- cyclical fever followed by periods of being afebrile for 1-2 weeks (rare)
Abdominal pain (if abdominal lymphadenopathy is involved)
Pruritus (30%)
Clinical hepato/splenomegaly is rare (although liver and spleen involvement determined by laparoscopy/laparotomy occurs in up to 30% of the patients)
Bone marrow involvement (5-8%)
systemic - ‘B symptoms’ (25%)
* weight loss
* pruritus
* night sweats
* fever (Pel-Ebstein)
Describe the Cotswolds-modified Ann Arbor staging system for HL [5]
Stage I - limited to a single lymph node region.
Stage II - two or more lymph node regions involved, on the same side of the diaphragm.
Stage III - lymph node regions involved on both sides of the diaphragm.
Stage IV - spread to other organs, such as liver, spleen, or bone marrow, with or without nodal involvement.
Each stage is followed by a letter:
- A - without B symptoms.
- B - with B symptoms, including fever, weight loss, night sweats.
- E - an extra-nodal site involved, that is localised to the known lymph node region.
- X - bulky disease: mediastinal mass exceeds 1/3 of the intrathoracic diameter or nodal mass >10cm in dimension.
Describe the treatment plan for Stage I/II classical Hodgkin’s lymphoma [2]
and
Stage III/ IV classical Hodgkin’s lymphoma [2]
Stage I/II classical Hodgkin’s lymphoma:
- Chemotherapy followed by radiotherapy
- Main treatment regimen: ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) + radiotherapy
Stage III/ IV classical Hodgkin’s lymphoma:
- Chemotherapy alone: ABVD or BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisolone)
Describe the treatment plan for Stage I/ II nodular lymphocyte-predominant Hodgkin’s lymphoma: [1]
and
Stage III/ IV nodular lymphocyte-predominant Hodgkin’s lymphoma [2]
Stage I/ II nodular lymphocyte-predominant Hodgkin’s lymphoma:
- Involved-field radiotherapy alone is the main treatment for this group of patients with excellent clinical benefit.
Stage III/ IV nodular lymphocyte-predominant Hodgkin’s lymphoma:
- R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) is administered in symptomatic patients or those with rapid disease progression .
- Regular monitoring is adequate in asymptomatic patients.
Describe the management plan for HL in refractory disease [2]
Chemotherapy followed by autologous stem cell transplantation (ASCT)
Immunotherapeutic agents can be considered:
- Brentuximab vedotin
- nivolumab
- pembrolizumab